Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.
Fuente:
Redalyc
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artículo científico |
| Sprache: | en |
| Veröffentlicht: |
Instituto Nacional de Salud Pública
2007
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1876478261101330432 |
|---|---|
| author | Emily Faye White |
| author_facet | Emily Faye White |
| contents | Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Emily Faye White Richard S. Garfein Kimberly C. Brouwer Remedios Lozada Michelle Firestone-Cruz Saida G. Pérez Carlos J. Conde-Glez Steffanie A. Strathdee Rebeca Ramos Carlos Magis-Rodríguez Salud Mexico needle sharing Hepatitis C virus injection drug use human immunodeficiency virus Objective. To estimate the prevalence of the hepatitis Cvirus (HCV) and HIV infection and associated risk behaviorsamong injection drug users (IDUs) in two northern Mexicancities. Material and Methods. Between February and April2005, IDUs were recruited in Tijuana (N=222) and CiudadJuarez (N=206) using respondent-driven sampling (RDS), achain referral sampling approach. Interviewer-administeredquestionnaires assessed drug-using behaviors during the priorsix months. Venous blood was collected for immunoassays todetect HIV and HCV antibodies. For HIV, Western blot orimmunofluorescence assay was used for confirmatory testing.Final HCV antibody prevalence was estimated using RDSadjustments. Results. Overall, HCV and HIV prevalence was96.0% and 2.8%, respectively, and was similar in both cities.Most IDUs (87.5%) reported passing on their used injectionequipment to others, and 85.9% had received used equipmentfrom others. Conclusions. HIV prevalence was relatively highgiven the prevalence of HIV in the general population, andHCV prevalence was extremely high among IDUs in Tijuanaand Ciudad Juarez. Frequent sharing practices indicate a highpotential for continued transmission for both infections. HCV counseling and testing for IDUs in Mexico and interventionsto reduce sharing of injection equipment are needed. 2007 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10649301 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.3 Vol.49 |
| format | Artículo científico |
| id | redalyc_10649301 |
| institution | Redalyc |
| language | en |
| publishDate | 2007 |
| publisher | Instituto Nacional de Salud Pública |
| spellingShingle | Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Emily Faye White Salud Mexico needle sharing Hepatitis C virus injection drug use human immunodeficiency virus Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Emily Faye White Richard S. Garfein Kimberly C. Brouwer Remedios Lozada Michelle Firestone-Cruz Saida G. Pérez Carlos J. Conde-Glez Steffanie A. Strathdee Rebeca Ramos Carlos Magis-Rodríguez Salud Mexico needle sharing Hepatitis C virus injection drug use human immunodeficiency virus Objective. To estimate the prevalence of the hepatitis Cvirus (HCV) and HIV infection and associated risk behaviorsamong injection drug users (IDUs) in two northern Mexicancities. Material and Methods. Between February and April2005, IDUs were recruited in Tijuana (N=222) and CiudadJuarez (N=206) using respondent-driven sampling (RDS), achain referral sampling approach. Interviewer-administeredquestionnaires assessed drug-using behaviors during the priorsix months. Venous blood was collected for immunoassays todetect HIV and HCV antibodies. For HIV, Western blot orimmunofluorescence assay was used for confirmatory testing.Final HCV antibody prevalence was estimated using RDSadjustments. Results. Overall, HCV and HIV prevalence was96.0% and 2.8%, respectively, and was similar in both cities.Most IDUs (87.5%) reported passing on their used injectionequipment to others, and 85.9% had received used equipmentfrom others. Conclusions. HIV prevalence was relatively highgiven the prevalence of HIV in the general population, andHCV prevalence was extremely high among IDUs in Tijuanaand Ciudad Juarez. Frequent sharing practices indicate a highpotential for continued transmission for both infections. HCV counseling and testing for IDUs in Mexico and interventionsto reduce sharing of injection equipment are needed. 2007 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10649301 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.3 Vol.49 |
| title | Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. |
| topic | Salud Mexico needle sharing Hepatitis C virus injection drug use human immunodeficiency virus |
| url | https://www.redalyc.org/articulo.oa?id=10649301 |